Latest News about NVO
Recent news which mentions NVO
Setback For Novo Nordisk? Denmark Shifts Prescription Guidelines, Favoring Cost-Effective Alternatives For Ozempic
May 01, 2024
From Benzinga
From Motley Fool
From InvestorPlace
From Motley Fool
Is Viking Therapeutics Incredibly Undervalued?
April 28, 2024
From Motley Fool
Forget Nvidia, These Unstoppable Stocks Are Better Buys
April 27, 2024
From Motley Fool
From Motley Fool
From Benzinga
What Are Pricing Strategies for Ozempic And Wegovy With Potential Medicare Coverage Expansion? Senate Committee Questions Novo Nordisk
April 24, 2024
From Benzinga
3 Biotech Stocks With Skyrocketing Potential: April 2024
April 24, 2024
From InvestorPlace
From Motley Fool
From InvestorPlace
From Motley Fool
Better Buy: Pfizer vs. Viking Therapeutics
April 23, 2024
From Motley Fool
From InvestorPlace
Changing Frugal Eating Habits - How Novo Nordisk/Eli Lilly's Weight Loss Drugs Reshaping Food Spending
April 22, 2024
From Benzinga
From Motley Fool
3 Relatively Safe Growth Stocks You Can Buy and Hold
April 20, 2024
From Motley Fool
3 Biotech Stocks Set to Double by 2028
April 20, 2024
From InvestorPlace
Got $500? 3 Healthcare Stocks to Buy and Hold Forever
April 19, 2024
From Motley Fool
German Authority Gives Go Ahead To Novo Nordisk's Small Bolt On Acquisition As Danish Firm Seeks To Build Heart Drugs Pipeline
April 18, 2024
From Benzinga
Patients Find Weight Loss Drug Zepbound A Game Changer, But Makers See Production Delay Until 2025
April 18, 2024
From Benzinga
From Motley Fool
From InvestorPlace
From InvestorPlace
3 Pharma Stocks That Are Money-Printing Machines in 2024
April 15, 2024
From InvestorPlace
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.